UBS Group’s Healthcare Services Acquisition Corporation Unit HCARU Stock Holding History

UBS Group’s Portfolio HCARU Stock Details HCARU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,425	Closed	-$193K	–	11611
2022 Q3	$193K	Buy	19,425 +25	+0.1%	+$247	﹤0.01%	5120
2022 Q2	$191K	Sell	19,400 -10,000	-34%	-$98.8K	﹤0.01%	4959
2022 Q1	$292K	Sell	29,400 -164	-0.6%	-$1.63K	﹤0.01%	5083
2021 Q4	$294K	Sell	29,564 -812	-3%	-$8.14K	﹤0.01%	5379
2021 Q3	$301K	Sell	30,376 -215	-0.7%	-$2.15K	﹤0.01%	5042
2021 Q2	$307K	Sell	30,591 -1,459	-5%	-$14.7K	﹤0.01%	5072
2021 Q1	$321K	Buy	32,050 +17,050	+114%	+$181K	﹤0.01%	5172
2020 Q4	$153K	Buy	+15,000	New	+$154K	﹤0.01%	5415

UBS Group's HCARU Position: Q4 2022 in Review

UBS Group sold out of Healthcare Services Acquisition Corporation Unit (HCARU) in Q4 2022, closing a stake of 19,425 shares — an estimated $193K sold.

UBS Group first reported a position in HCARU in Q4 2020 and held it in 8 quarters. The position peaked at $321K in Q1 2021. 0 funds tracked by Wall St. Rank hold HCARU as of Q4 2022.

UBS Group reported no remaining Healthcare Services Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
UBS Group sold 19,425 Healthcare Services Acquisition Corporation Unit shares in Q4 2022, an estimated $193K.
UBS Group first reported a position in Healthcare Services Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
UBS Group's Healthcare Services Acquisition Corporation Unit position peaked at $321K in Q1 2021.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.